In the tumor microenvironment, overexpressed PD-L1 is capable of interacting with PD-1 on sensitized immune cells, inducing T cell proliferation suppression and the production of cytokines, such as interferon-γ (IFN-γ) and interleukin 2 (IL-2). Here, PDCD1 is linked to neoplasm.